These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14593202)

  • 1. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment.
    Marino MJ; Williams DL; O'Brien JA; Valenti O; McDonald TP; Clements MK; Wang R; DiLella AG; Hess JF; Kinney GG; Conn PJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13668-73. PubMed ID: 14593202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse.
    Valenti O; Marino MJ; Wittmann M; Lis E; DiLella AG; Kinney GG; Conn PJ
    J Neurosci; 2003 Aug; 23(18):7218-26. PubMed ID: 12904482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons.
    Valenti O; Mannaioni G; Seabrook GR; Conn PJ; Marino MJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1296-304. PubMed ID: 15761115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats.
    Stachowicz K; Kłak K; Kłodzińska A; Chojnacka-Wojcik E; Pilc A
    Eur J Pharmacol; 2004 Sep; 498(1-3):153-6. PubMed ID: 15363989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of excitatory transmission at PF-PC synapse by group III metabotropic glutamate receptors is provided exclusively by mGluR4 in the rodent cerebellar cortex.
    Abitbol K; Acher F; Daniel H
    J Neurochem; 2008 Jun; 105(6):2069-79. PubMed ID: 18266929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.
    Le Poul E; Boléa C; Girard F; Poli S; Charvin D; Campo B; Bortoli J; Bessif A; Luo B; Koser AJ; Hodge LM; Smith KM; DiLella AG; Liverton N; Hess F; Browne SE; Reynolds IJ
    J Pharmacol Exp Ther; 2012 Oct; 343(1):167-77. PubMed ID: 22787118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
    Kłak K; Pałucha A; Brański P; Sowa M; Pilc A
    Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors.
    Beqollari D; Kammermeier PJ
    Eur J Pharmacol; 2008 Jul; 589(1-3):49-52. PubMed ID: 18593581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection.
    Maj M; Bruno V; Dragic Z; Yamamoto R; Battaglia G; Inderbitzin W; Stoehr N; Stein T; Gasparini F; Vranesic I; Kuhn R; Nicoletti F; Flor PJ
    Neuropharmacology; 2003 Dec; 45(7):895-906. PubMed ID: 14573382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
    Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
    Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive allosteric modulator of mGluR4 PHCCC exhibits proconvulsant action in three models of epileptic seizures in immature rats.
    Szczurowska E; Mareš P
    Physiol Res; 2012; 61(6):619-28. PubMed ID: 23098651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's disease.
    Lindsley CW; Niswender CM; Engers DW; Hopkins CR
    Curr Top Med Chem; 2009; 9(10):949-63. PubMed ID: 19754407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.
    Hopkins CR; Lindsley CW; Niswender CM
    Future Med Chem; 2009 Jun; 1(3):501-13. PubMed ID: 20161443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
    Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
    Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.
    Marino MJ; Conn PJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):98-102. PubMed ID: 16368268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors.
    Gammon JM; Adapa AR; Jewell CM
    J Biomed Mater Res A; 2017 Nov; 105(11):2977-2985. PubMed ID: 28646511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
    Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
    Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
    Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
    Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.